Substitution therapy | Virtual Summit 2020

Despite significant paradigm shifts in the medical management of hemophilia A with inhibitors and the expanding use of novel non-factor therapies, FVIII-based immune tolerance induction (ITI) is still the only effective means to inhibitor eradication. With the recently introduced Atlanta protocol, emicizumab prophylaxis is given in combination with 50-100 IU/kg FVIII three times a week. […]

Laboratory sciences: Laboratory issues and testing | Virtual Summit 2020

In this session from the WFH 2020 Virtual Summit, Steve Kitchen, Stefen Tiefenbacher, Anna Lowe and Annette Bowyer discuss: Gene therapy for FVIII and FIX: Will there be laboratory assay issues? Laboratory issues with isolated emicizumab therapy Laboratory issues when emicizumab and FVIII replacement are combined The WFH does not engage in the practice of […]

Free papers: Young researchers | Virtual Summit 2020

In this session from the WFH 2020 Virtual Summit, Cedric Hermans, Geertje Goedhart, Patricio Cesar Gatti, Sandeep Albert, Tien-Truong Dang, Ozlem Turan and Glaivy Batsuli discuss: “The Dutch Haemophilia Registry HemoNED – building an Ecosystem” “Evaluation of treatment with dental implants in patients with hemophilia preliminary study” “Surgical management of a variety of haemophilic pseudotumours […]

Inhibitors in Hemophilia: A Primer – Traditional Chinese

Also Available In: English, Spanish This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for […]

CDC Webinar: Overview of WFH Treatment Guidelines, 3rd Edition

On December 10th, 2020 Glenn Pierce, WFH VP Medical moderated this one-hour webinar in the Public Health Webinar Series on Blood Disorders presented by the CDC. The webinar discussed how the WFH Guidelines for the Management of Hemophilia, 3rd edition provides opportunities to improve the standard of diagnosis and care for people with hemophilia around […]

ePosters of the XXXIII International Congress of the World Federation of Hemophilia

This interactive carousel features over 350 posters presented at the WFH 2018 World Congress, which can be searched by title, author, poster number, or topic. Via the Options tab on the right, viewers may download, print, or email posters; email poster authors directly; or participate in an online discussion. Presentation slides can also be viewed […]

Inhibitors in Hemophilia: A Primer

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Traditional Chinese Inhibitors are a serious complication of hemophilia caused by an immune response to clotting factor concentrates. Treatment of inhibitors is one of the biggest challenges in hemophilia care today. This primer explains our current understanding of […]